Self- or caregiver administration of epinephrine is considered the treatment of choice for acute anaphylaxis (1). In June 2017, US FDA approved Symjepi™, a prefilled syringe used for the administration of epinephrine (2).
http://ift.tt/2Fc2mbE
OtoRhinoLaryngology by Alexandros G.Sfakianakis,,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,tel : 00302841026182,00306932607174
Τρίτη 27 Φεβρουαρίου 2018
Human factors study in untrained adolescents comparing an epinephrine prefilled syringe (symjepi™) with EpiPen® autoinjector
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου